메뉴 건너뛰기




Volumn 24, Issue 1, 2004, Pages 102-103

Reply to Article by Margolese and Associates on Tolerance and Rebound during Maintenance with Quetiapine [8]

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

EID: 1642498204     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000106231.36344.f8     Document Type: Letter
Times cited : (2)

References (3)
  • 1
    • 0036323747 scopus 로고    scopus 로고
    • Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder
    • Margolese HC, Chouinard G, Beauclair L, et al. Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder. J Clin Psychopharmacol. 2002;22:347-352.
    • (2002) J Clin Psychopharmacol , vol.22 , pp. 347-352
    • Margolese, H.C.1    Chouinard, G.2    Beauclair, L.3
  • 2
    • 0036307453 scopus 로고    scopus 로고
    • Relapse and rehospitalisation rates in patients with schizophrenia: Effects of second generation antipsychotics
    • Csernansky JG, Schuchart EK. Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics. CNS Drugs. 2002;16:473-484.
    • (2002) CNS Drugs , vol.16 , pp. 473-484
    • Csernansky, J.G.1    Schuchart, E.K.2
  • 3
    • 0031681401 scopus 로고    scopus 로고
    • Pharmacological prevention of relapse
    • Lader M. Pharmacological prevention of relapse. Kaohsiung J Med Sci. 1998;14:448-457.
    • (1998) Kaohsiung J Med Sci , vol.14 , pp. 448-457
    • Lader, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.